Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Minority Interest (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Minority Interest for 5 consecutive years, with $705.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Minority Interest rose 103.46% year-over-year to $705.0 million, compared with a TTM value of $705.0 million through Dec 2025, up 103.46%, and an annual FY2025 reading of $499.6 million, up 4.09% over the prior year.
  • Minority Interest was $705.0 million for Q4 2025 at Roivant Sciences, up from $443.1 million in the prior quarter.
  • Across five years, Minority Interest topped out at $705.0 million in Q4 2025 and bottomed at $22.5 million in Q2 2021.
  • Average Minority Interest over 5 years is $349.7 million, with a median of $423.4 million recorded in 2023.
  • The sharpest move saw Minority Interest surged 1782.57% in 2023, then fell 29.97% in 2024.
  • Year by year, Minority Interest stood at $22.5 million in 2021, then skyrocketed by 1471.95% to $353.5 million in 2022, then soared by 39.96% to $494.8 million in 2023, then dropped by 29.97% to $346.5 million in 2024, then soared by 103.46% to $705.0 million in 2025.
  • Business Quant data shows Minority Interest for ROIV at $705.0 million in Q4 2025, $443.1 million in Q3 2025, and $470.3 million in Q2 2025.